Sequoia Financial Advisors LLC Has $515,000 Holdings in CVS Health Corporation (CVS)
Sequoia Financial Advisors LLC raised its position in shares of CVS Health Corporation (NYSE:CVS) by 0.8% in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 6,406 shares of the pharmacy operator’s stock after buying an additional 53 shares during the period. Sequoia Financial Advisors LLC’s holdings in CVS Health Corporation were worth $515,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently made changes to their positions in CVS. Gemmer Asset Management LLC boosted its position in CVS Health Corporation by 15.3% during the 2nd quarter. Gemmer Asset Management LLC now owns 1,509 shares of the pharmacy operator’s stock valued at $121,000 after buying an additional 200 shares during the period. TB Alternative Assets Ltd. purchased a new stake in CVS Health Corporation during the 2nd quarter valued at $121,000. SRS Capital Advisors Inc. boosted its position in CVS Health Corporation by 48.2% during the 1st quarter. SRS Capital Advisors Inc. now owns 2,256 shares of the pharmacy operator’s stock valued at $177,000 after buying an additional 734 shares during the period. Grace & White Inc. NY purchased a new stake in CVS Health Corporation during the 2nd quarter valued at $199,000. Finally, Nadler Financial Group Inc. purchased a new stake in CVS Health Corporation during the 2nd quarter valued at $202,000. 82.04% of the stock is owned by institutional investors and hedge funds.
Shares of CVS Health Corporation (CVS) opened at $71.48 on Tuesday. The firm has a market cap of $71,912.30, a PE ratio of 12.43, a price-to-earnings-growth ratio of 1.22 and a beta of 0.86. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.55 and a current ratio of 1.05. CVS Health Corporation has a 12 month low of $66.45 and a 12 month high of $84.72.
CVS Health Corporation (NYSE:CVS) last released its quarterly earnings data on Monday, November 6th. The pharmacy operator reported $1.50 earnings per share for the quarter, beating analysts’ consensus estimates of $1.49 by $0.01. The business had revenue of $46.18 billion during the quarter, compared to analyst estimates of $46.17 billion. CVS Health Corporation had a net margin of 2.77% and a return on equity of 16.96%. CVS Health Corporation’s revenue was up 3.5% compared to the same quarter last year. During the same period last year, the business earned $1.64 EPS. equities research analysts predict that CVS Health Corporation will post 5.89 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 3rd. Shareholders of record on Tuesday, October 24th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Monday, October 23rd. This represents a $2.00 dividend on an annualized basis and a yield of 2.80%. CVS Health Corporation’s dividend payout ratio is currently 41.32%.
CVS has been the subject of several analyst reports. SunTrust Banks, Inc. set a $85.00 price target on shares of CVS Health Corporation and gave the company a “buy” rating in a research report on Thursday, October 12th. Oppenheimer Holdings, Inc. reaffirmed a “buy” rating and issued a $95.00 target price on shares of CVS Health Corporation in a research report on Monday, October 9th. Mizuho set a $90.00 target price on shares of CVS Health Corporation and gave the stock a “buy” rating in a research report on Tuesday, October 24th. Cowen and Company set a $86.00 target price on shares of CVS Health Corporation and gave the stock a “buy” rating in a research report on Sunday, October 29th. Finally, Needham & Company LLC raised shares of CVS Health Corporation from a “hold” rating to a “buy” rating and raised their target price for the stock from $69.02 to $79.00 in a research report on Friday. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and fourteen have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus target price of $85.82.
TRADEMARK VIOLATION NOTICE: This piece of content was originally published by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this piece of content on another website, it was illegally stolen and republished in violation of U.S. & international trademark and copyright law. The correct version of this piece of content can be accessed at https://www.thecerbatgem.com/2017/11/14/sequoia-financial-advisors-llc-has-515000-holdings-in-cvs-health-corporation-cvs.html.
In other news, insider Larry J. Merlo sold 241,150 shares of CVS Health Corporation stock in a transaction that occurred on Wednesday, September 13th. The shares were sold at an average price of $83.07, for a total value of $20,032,330.50. Following the completion of the sale, the insider now directly owns 299,255 shares in the company, valued at $24,859,112.85. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Thomas M. Moriarty sold 90,267 shares of CVS Health Corporation stock in a transaction that occurred on Monday, September 11th. The stock was sold at an average price of $79.61, for a total transaction of $7,186,155.87. Following the completion of the sale, the executive vice president now owns 70,102 shares of the company’s stock, valued at $5,580,820.22. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 716,625 shares of company stock valued at $58,318,431. 0.61% of the stock is owned by company insiders.
CVS Health Corporation Company Profile
CVS Health Corporation, together with its subsidiaries, is an integrated pharmacy healthcare company. The Company provides pharmacy care for the senior community through Omnicare, Inc (Omnicare) and Omnicare’s long-term care (LTC) operations, which include distribution of pharmaceuticals, related pharmacy consulting and other ancillary services to chronic care facilities and other care settings.
Receive News & Stock Ratings for CVS Health Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health Corporation and related stocks with our FREE daily email newsletter.